At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Munich based CFO’ operating in the Medical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
CFO & Co-Founder of Bestsmile
Co-founder and managing director Alexander Henn is mainly responsible for markets, marketing and business development. He first accessed the digital world during the stock market boom in 1999 with the Boersen-Investor.de exchange platform and founded the first German shop for vitamin products at the age of 15. He later founded other companies such as the online shop Libute.de and Xantera AG. This young entrepreneur graduated from high school by taking evening classes in Munich and then, in addition to his professional activity, studied law at Ludwig-Maximilians-Universität in Munich. During his free time, Alexander Henn devotes himself to politics and history and relaxes listening to classical or electronic music.
Follow Philip Magoulas:
About Bestsmile: Bestsmile is an orthodontics company that specializes in clear aligner and veneer treatments for your teeth.
Managing Director and CFO of GNA Biosolutions
Federico holds the post of Managing Director and CFO of GNA Biosolutions. His primary responsibilities are GNA’s finances as well technology-wise for the optoelectronic and software development. Federico has started his entrepreneurial career in high school and thus gained many years of business planning experience. Federico began his undergraduate studies of physics at the University of Munster/Germany and then enrolled at the Universities of Wurzburg/Germany and the University of Texas at Austin, where he earned his Master’s degree in physics in 2003. During his entire studies Federico was a fellow of the German National Academic Foundation (Studienstiftung). Afterwards, Federico moved to Munich/Germany where he worked in the Center for nanoscience and obtained his PhD in physics from Ludwig-Maximilians-Universität in 2008. He is author and co-author of 16 peer-reviewed scientific papers on detection technology.
Follow Federico Bursgens:
About GNA Biosolutions: GNA Biosolutions is a private molecular diagnostics company.
CFO & Co-Founder of Breath Therapeutics
Anne Burger has over 15 years expertise in senior finance functions for biotech and Medtech companies throughout Europe and has served as lead advisor in numerous transactions, financings and structuring projects. Recently, Burger was CFO for Rigontec GmbH, an immune-oncology biotechnology company. She supported Rigontec’s fundraising activities and had an active role in the execution of the Trade sale to MSD (deal volume up to 464 M€). Throughout her career, Burger held several CFO and advisor positions in the life sciences and healthcare sector and was responsible for fundraising, executing trade sales and licensing agreements, and preparing for IPOs. Burger earned a graduate degree in Business Administration (Ludwig-Maximilian-Universität Munich, Honors) and successfully passed graduate studies in public health (Ludwig-Maximilian-Universität Munich).
Follow Anne Burger:
About Breath Therapeutics, Catalym: Breath Therapeutics is a private clinical-stage biopharmaceutical company.
Co-Founder and CFO of Mecuris
Follow Wolf-Peter Werner:
About Mecuris: Mecuris develops tailor-made prostheses and orthoses from the 3D printer.
Managing Director and Chief Financial Officer of leon nanodrugs
Christian Nafe is the Managing Director & Chief Financial Officer of leon-nanodrugs.He brings in more than 25 years of successfully working in corporate finance, controlling and finance. Christian held leading management positions in different roles in worldwide operating companies, since 2000 with a focus on life sciences. During this time, he successfully managed numerous license contracts, asset and share deals as well as supply agreements. He recently served as CEO/CFO at BioNet Holding GmbH, BioNet Ventures GmbH and BioNet Pharma GmbH (former Scil Technology GmbH). Christian graduated with honors as Dipl. Kaufmann in Business Administration from University Regensburg.
Follow Christian Nafe:
About leon nanodrugs: leon-nanodrugs is a nanotechnology-based drug development company.
CFO of Activaero
Dr. Fischer joined Affimed in 2005 as CFO on a part-time basis, transitioning into the full time CFO position at the Company’s IPO in 2014. Florian has a strong track record in various Biotech/MedTech executive positions, as lead advisor in a variety of transactions and financings in the life sciences and healthcare sector. Dr. Fischer is founder of MedVenture Partners – a corporate finance and strategy advisory company focusing on the life sciences and healthcare industry. Dr. Fischer was Chief Financial Officer of Activaero GmbH from 2002 until 2011 and responsible for corporate development until Activaero’s acquisition by Vectura in 2014. He also served as Chief Financial Officer of Vivendy Ltd. from 2008 until 2013 and as Managing Director of AbCheck in 2009. Prior to founding MedVenture Partners, Dr. Fischer worked with KPMG for more than six years until 2002, where he was responsible for biotech and healthcare assignments. Before joining KPMG, he worked for Deutsche Bank AG. Dr. Fischer is also a Director of Amphivena. He holds a graduate degree in business administration from Humboldt University, Berlin and a Ph.D. in public health from the University of Bielefeld.
Follow Florian Fischer:
About Activaero, Affimed: Activaero develops breathing technologies for patients suffering from severe respiratory diseases.
CFO of Rigontec
Follow Anne Burger:
About Rigontec: Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.
Co-Founder and CFO of MEDIKURA
Follow Philipp Naegelein:
About MEDIKURA: MEDIKURA develops digital infrastructure for drug safety. The goal is to make the drug safety as safe as possible.
Albert Christian Schauer
Chief Financial Officer of Avra Medical Robotics
Albert Christian Schauer, BRA, CPA, CTA has been Chief Financial Officer of AVRA Surgical Robotics Inc. and serves as its Principal Accounting Officer. Albert Schauer has been President and Chief Executive Officer of PharmOptima LLC, a pre-clinical contract research company based in Portage, Michigan. He served as the Chief Executive Officer of Eimo Technologies, Inc. and also served as its Chief Financial Officer. Following almost 10 years with Ernst & Young(formerly Ernst & Ernst ) in Kalamazoo and Cleveland, he joined Clausing Corporation in 1974 as Chief Financial Officer, and served that Company for 25 years in various senior management positions, the last 15 years as Chairman and Chief Executive Officer. For the prior 15 years, he was employed by Clausing Industrial Inc., a subsidiary of The 600 Group PLC, headquartered in the United Kingdom.
Follow Albert Christian Schauer:
About Avra Medical Robotics: AVRA was organized by a senior leadership team with broad and deep experience in medical research, innovation